Short Summary
Vicor and Delta Electronics filed a joint request to keep their IPR settlement agreement confidential under federal statutes.
Detailed Summary
In IPR2024-00705 concerning U.S. Patent 9,819,263, Vicor Corporation and Delta Electronics, Inc. submitted a joint motion requesting that their settlement agreement be treated as business‑confidential information pursuant to 35 U.S.C. §317(b) and 37 C.F.R. §42.74(c). The request emphasizes that the settlement should be kept separate from the public IPR file and disclosed only to government agencies or parties demonstrating good cause, thereby protecting the terms from public disclosure.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Vicor Corporation vs Delta Electronics, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
MPL Brands NV, Inc.vsBuzzBallz, LLC
BuzzBallz, LLC asks the PTAB Director to vacate the institution of a post‑grant review on its pre‑AIA design patent, arguing the Board misapplied written‑description standards and ignored expert testimony.
Samsung Electronics Co., Ltd. et al.vsWilus Institute of Standards and Technology Inc.
Samsung Electronics successfully secured the institution of an IPR against Wilus Institute's patent, challenging claims related to OFDMA scheduling and parameter switching.
Apple Inc.vsIngenioSpec, LLC
Apple has filed a petition for IPR of IngenioSpec’s U.S. Patent 8,582,789 covering a hearing‑enhancement system, seeking cancellation of all 76 challenged claims as obvious over Anderson and other prior‑art patents.
Sarepta Therapeutics, Inc. et al.vsGenzyme Corporation et al.
The USPTO Board denied the institution of IPR proceedings (IPR2025-01194) involving Sarepta Therapeutics and Genzyme Corporation, meaning no trial will proceed on the challenged patent.
RegenX Science Inc.vsNeXtGen Biologics, Inc.
Bankruptcy court approved a settlement between ISE and Synogen parties, including patent assignments and cash payments, leading to dismissal of related disputes.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.